Latest Funding And Capital Raises News

McLaren Minerals has successfully raised A$3.6 million through an oversubscribed entitlement offer, positioning the company to advance its McLaren titanium project in Western Australia.

Algorae Pharmaceuticals has announced a non-renounceable Loyalty Options Offer to eligible shareholders, aiming to raise up to $337,678 before costs, with potential additional capital of $4.7 million if all options are exercised. The capital raise supports the company’s pharmaceutical and AI research and development ambitions.

Austral Resources Australia Ltd is poised to resume trading on the ASX following a successful $40 million placement, marking a significant step in its recovery and future growth plans.

McLaren Minerals has launched a fully underwritten A$3.6 million entitlement offer to accelerate development of its McLaren titanium project, offering shareholders discounted shares and options.

Cavalier Resources has raised $2.14 million through a discounted share placement to fund a 5,000m extensional drilling program at its Crawford Gold Project, aiming to underpin future mining stages. The revised Pre-Feasibility Study confirms robust economics with a strong NPV and IRR.

Carnegie Clean Energy marked steady progress in Q3 2025, hitting key manufacturing milestones for its CETO wave energy system in Spain, securing €4 million in EU funding, and raising $2.1 million from shareholders to fuel commercialisation efforts.

McLaren Minerals reported a challenging quarter with net cash outflows and limited funding runway, prompting plans for a capital raise to support its upcoming Bankable Feasibility Study.

Australian Oil Company Limited has announced an $800,000 capital raising through a two-tranche share placement aimed at advancing its Californian oil and gas projects and exploring new growth opportunities.

Sarama Resources has completed the third tranche of its A$2.7 million equity placement, raising A$100,000 to advance exploration at its Cosmo Gold Project and support ongoing arbitration efforts.

Catapult Sports has launched a Share Purchase Plan (SPP) offering eligible shareholders in Australia and New Zealand the chance to buy up to A$30,000 in shares at a discount, following a successful A$130 million institutional placement. The capital raise supports the recent acquisition of IMPECT GmbH and future strategic opportunities.

Australian Strategic Materials secures A$50.8 million via share placement to fund Korean plant expansion and advance US metals project, while navigating complex supply chain and funding risks.

EVE Health Group Limited has launched a $1.1 million capital raising via a placement to fund the commercial rollout of its two pharmaceutical products, Dyspro and Libbo. The offer includes shares and options, with some subject to shareholder approval.